Twist Bioscience (TWST) Stock Price, Quote, News & History | Benzinga

Twist Bioscience Corp (TWST) Stock Price, Quote, News & History

TWSTNASDAQ

Trade with Public

Trade with Public

$116.10

-8.31-6.68%

At close: Aug 18, 5:00 PM EST

$117.50

1.401.21%

After Hours: 7:36 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$121.61

Close

$116.10

Volume / Avg.

1.30M / 1.77M

Day Range

$115.28 - $123.30

52 Wk Range

23.30 - 126.40

Market Cap

$7.18B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

59

Short Interest

25.93%

Days to Cover

11.12

Recent Twist Bioscience Corporation News

Twist Bioscience Sees AI Drug Discovery Pipeline Expand

Twist Bioscience (NASDAQ: TWST) stock is up on strong Q3 results and raised guidance. AI drug discovery and NGS businesses show growth.

Vandana Singh

These Analysts Boost Their Forecasts On Twist Bioscience After Q2 Results

Twist Bioscience Corp (TWST) reported Q2 loss but exceeded sales guidance. CEO expects profitability and raised FY sales guidance. Analysts raise price targets.

Avi Kapoor

This UFP Industries Analyst Turns Bullish; Here Are Top 4 Upgrades For Tuesday

Top Wall Street analysts changed outlook on top names. Check analyst ratings page for full changes. See other analysts' views on UFPI, TWST, BMA, and PAC.

Avi Kapoor

Crowdstrike To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Tuesday

Top analysts change outlooks on top names: UBS raises price target for TD Synnex, BMO Capital raises target for Goldman Sachs, Citigroup raises target for Pinterest, and more.

Avi Kapoor

AI-Driven Demand Boosts Twist Bioscience Sales, But Loss Widens

Twist Bioscience posts wider Q2 loss, beats revenue estimates, raises FY26 outlook, and expands gene portfolio.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-53.07M

Investing Cash Flow (TTM)

-45.24M

Financing Cash Flow (TTM)

13.80M

Free Cash Flow (TTM)

-93.22M

Capital Expenditure (TTM)

-40.15M

Net Change in Cash (TTM)

-84.52M

Analyst Trends and Forecast

4

May

5

Jun

1

Jul

2

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.3

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$7.73B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

17.59

PB Ratio (TTM)

17.50

Earnings Yield % (TTM)

-1.79%

Earnings Yield % (FWD)

-0.40%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$7.11

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$117.44M

Debt to Equity

0.21

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$121.61

Close

$116.10

Volume / Avg.

1.30M / 1.77M

Day Range

$115.28 - $123.30

52 Wk Range

23.30 - 126.40

Market Cap

$7.18B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

59

Short Interest

25.93%

Days to Cover

11.12

About

Sector

Health Care

Industry

Biotechnology

Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon ra...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Twist Bioscience (TWST) stock?

A

You can purchase shares of Twist Bioscience (NASDAQ:TWST) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Twist Bioscience (TWST) competitors?

A

Other companies in Twist Bioscience’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Twist Bioscience (TWST) stock?

A

Twist Bioscience has a consensus price target of $72.06.

Q

What is the current price for Twist Bioscience (TWST)?

A

The stock price for Twist Bioscience (NASDAQ: TWST) is $117.5 last updated August 18, 2026 at 7:36 PM EDT.

Q

Does Twist Bioscience (TWST) pay a dividend?

A

There are no upcoming dividends for Twist Bioscience.

Q

When is Twist Bioscience (NASDAQ:TWST) reporting earnings?

A

Twist Bioscience does not have any upcoming earnings scheduled.

Q

Is Twist Bioscience (TWST) going to split?

A

There is no upcoming split for Twist Bioscience.

Q

What sector and industry does Twist Bioscience (TWST) operate in?

A

Twist Bioscience is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.